SPIA
RGLS

Steward Partners Investment Advisory’s Regulus Therapeutics RGLS Stock Holding History

Steward Partners Investment Advisory’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8
Closed – – 2972
2020
Q3 		$0 Hold
8
– – ﹤0.01% 2833
2020
Q2 		$0 Hold
8
– – ﹤0.01% 2736
2020
Q1 		$0 Hold
8
– – ﹤0.01% 2669
2019
Q4 		$0 Hold
8
– – ﹤0.01% 2715
2019
Q3 		$0 Hold
8
– – ﹤0.01% 2741
2019
Q2 		$0 Buy
+8
New +$92 ﹤0.01% 2678
2018
Q4 		– Sell
-8
Closed – – 1849
2018
Q3 		$0 Hold
8
– – ﹤0.01% 2682
2018
Q2 		$1K Buy
+8
New +$662 ﹤0.01% 2380

Other funds holding RGLS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Steward Partners Investment Advisory's RGLS Position: Q4 2020 in Review

Steward Partners Investment Advisory sold out of Regulus Therapeutics (RGLS) in Q4 2020, closing a stake of 8 shares.

Steward Partners Investment Advisory first reported a position in RGLS in Q2 2018 and held it in 8 quarters. The position peaked at $1K in Q2 2018. 31 funds tracked by Wall St. Rank hold RGLS as of Q4 2020.

  • Steward Partners Investment Advisory reported no remaining Regulus Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 8 Regulus Therapeutics shares in Q4 2020.
  • Steward Partners Investment Advisory first reported a position in Regulus Therapeutics in Q2 2018 and held it in 8 quarters.
  • Steward Partners Investment Advisory's Regulus Therapeutics position peaked at $1K in Q2 2018.
  • 31 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q4 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2020, filed 11 Feb 2021.